| The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal … RM Cooper‐DeHoff, M Niemi, LB Ramsey, JA Luzum, EK Tarkiainen, ... Clinical Pharmacology & Therapeutics 111 (5), 1007-1021, 2022 | 146 | 2022 |
| The effect of gut metabolism on tacrolimus bioavailability in renaltransplant recipients1, 2 S Tuteja, RR Alloway, JA Johnson, AO Gaber Transplantation 71 (9), 1303-1307, 2001 | 135 | 2001 |
| Calcineurin inhibitor minimization, conversion, withdrawal, and avoidance strategies in renal transplantation: a systematic review and meta‐analysis D Sawinski, J Trofe‐Clark, B Leas, S Uhl, S Tuteja, JL Kaczmarek, ... American Journal of Transplantation 16 (7), 2117-2138, 2016 | 116 | 2016 |
| Projected prevalence of actionable pharmacogenetic variants and level A drugs prescribed among US Veterans Health Administration pharmacy users C Chanfreau-Coffinier, LE Hull, JA Lynch, SL DuVall, SM Damrauer, ... JAMA network open 2 (6), e195345-e195345, 2019 | 111 | 2019 |
| Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype‐Guided Antiplatelet Therapy PE Empey, JM Stevenson, S Tuteja, KW Weitzel, DJ Angiolillo, ... Clinical Pharmacology & Therapeutics 104 (4), 664-674, 2018 | 108 | 2018 |
| Trends in platelet adenosine diphosphate P2Y12 receptor inhibitor use and adherence among antiplatelet-naive patients after percutaneous coronary intervention, 2008-2016 EJ Dayoub, M Seigerman, S Tuteja, T Kobayashi, DM Kolansky, J Giri, ... JAMA internal medicine 178 (7), 943-950, 2018 | 96 | 2018 |
| Community pharmacists ‘attitudes towards clinical utility and ethical implications of pharmacogenetic testing S Tuteja, K Haynes, C Zayac, JE Sprague, B Bernhardt, R Pyeritz Personalized medicine 10 (8), 793-800, 2013 | 93 | 2013 |
| High‐density lipoproteins in the prevention of cardiovascular disease: changing the paradigm S Tuteja, DJ Rader Clinical Pharmacology & Therapeutics 96 (1), 48-56, 2014 | 90 | 2014 |
| The IGNITE Pharmacogenetics Working Group: an opportunity for building evidence with pharmacogenetic implementation in a real‐world setting LH Cavallari, AL Beitelshees, KV Blake, LG Dressler, JD Duarte, A Elsey, ... Clinical and translational science 10 (3), 143, 2017 | 88 | 2017 |
| Gut microbiome and response to cardiovascular drugs S Tuteja, JF Ferguson Circulation: Genomic and Precision Medicine 12 (9), e002314, 2019 | 84 | 2019 |
| COVID-19: understanding inter-individual variability and implications for precision medicine NL Pereira, F Ahmad, M Byku, NW Cummins, AA Morris, A Owens, ... Mayo Clinic Proceedings 96 (2), 446-463, 2021 | 72 | 2021 |
| Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing LH Cavallari, SL Van Driest, CA Prows, JR Bishop, NA Limdi, VM Pratt, ... Genetics in Medicine 21 (10), 2255-2263, 2019 | 58 | 2019 |
| Prospective CYP2C19 Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Pragmatic Randomized Clinical Trial S Tuteja, H Glick, W Matthai, I Nachamkin, A Nathan, K Monono, ... Circulation: Genomic and Precision Medicine 13 (1), e002640, 2020 | 54 | 2020 |
| Utilization of dried blood spot citrulline level as a noninvasive method for monitoring graft function following intestinal transplantation HC Yu, S Tuteja, JI Moon, GI Kleiner, L Conanan, JJ Gaynor, T Kato, ... Transplantation 80 (12), 1729-1733, 2005 | 53 | 2005 |
| Impact of acute rejection episodes on long-term graft survival following simultaneous kidney-pancreas transplantation KS Reddy, D Davies, D Ormond, S Tuteja, BA Lucas, TD Johnston, ... American Journal of Transplantation 3 (4), 439-444, 2003 | 48 | 2003 |
| Simvastatin‐ezetimibe‐induced hepatic failure necessitating liver transplantation S Tuteja, NT Pyrsopoulos, WR Wolowich, K Khanmoradi, DM Levi, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (9 …, 2008 | 47 | 2008 |
| Real-world integration of genomic data into the electronic health record: the PennChart Genomics Initiative KS Lau-Min, SB Asher, J Chen, SM Domchek, M Feldman, S Joffe, ... Genetics in Medicine 23 (4), 603-605, 2021 | 42 | 2021 |
| Prescribing prevalence of medications with potential genotype-guided dosing in pediatric patients LB Ramsey, HH Ong, JS Schildcrout, Y Shi, LA Tang, JK Hicks, ... JAMA network open 3 (12), e2029411-e2029411, 2020 | 39 | 2020 |
| APOL1 risk variants, acute kidney injury, and death in participants with African ancestry hospitalized with COVID-19 from the Million Veteran Program AM Hung, SC Shah, AG Bick, Z Yu, HC Chen, CM Hunt, F Wendt, ... JAMA internal medicine 182 (4), 386-395, 2022 | 36 | 2022 |
| Opportunity for genotype‐guided prescribing among adult patients in 11 US health systems JK Hicks, N El Rouby, HH Ong, JS Schildcrout, LB Ramsey, Y Shi, ... Clinical Pharmacology & Therapeutics 110 (1), 179-188, 2021 | 35 | 2021 |
